1,362 Shares
MatthewDavies (Active)
Create Post
  • Attachment
  • Are you human?
06/24/22 - 08:15 AM MatthewDavies created a new post.
06/24/22 - 08:14 AM MatthewDavies created a new post.
  • Account: 1362 SHARES. +84
  • Universal Ibogaine in the Virtual Growth Conference

    Universal Ibogaine Inc. is going to participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest.
    5783 views
  • 14 0

  • Comments
  • No comments yet.
06/24/22 - 08:10 AM MatthewDavies created a new post.
  • Account: 1362 SHARES. +156
  • $IBO’s Addiction treatment

    Universal Ibogaine Inc. is a life science company with a mission to transform addiction treatment through the use of medicalized ibogaine and a global licensing model through a planned Canadian Clinical trial.
    5792 views
  • 26 0

  • Comments
  • No comments yet.
06/23/22 - 10:15 AM MatthewDavies created a new post.
  • Account: 1362 SHARES. +144
  • $IBOGF CEO accentuates on the Importance of the research to reality event

    "The significance of this occasion cannot be emphasized," said Universal Ibogaine Inc. CEO Nick Karos. This is the first gathering of academic researchers, real-world technicians, and government policymakers of its sort. This event will raise awareness of ibogaine's great potential at the highest levels."
    6831 views
  • 24 0

  • Comments
  • No comments yet.
06/23/22 - 09:32 AM MatthewDavies created a new post.
  • Account: 1362 SHARES. +156
  • $IBO Nick Karos excited by listing of Universal Ibogaine Inc. on Frankfurt stock exchange

    Universal Ibogaine Inc. CEO made a statement "Our capital markets and investor relations strategy includes the FSE listing. We recently began trading on the OTCQB Exchange in the United States, and curiosity in the UI story is growing in Europe, particularly Germany. With a mushrooming market and interest in psychedelic medications, Germany has a reputation for innovation and leadership."
    6836 views
  • 26 0

  • Comments
  • No comments yet.
06/23/22 - 09:30 AM MatthewDavies created a new post.
06/22/22 - 10:38 AM MatthewDavies created a new post.
  • Account: 1362 SHARES. +84
  • Universal Ibogaine on achieving benevolent objective

    UI is a life sciences industry on a mission to show the safety and efficacy of its ibogaine-based drug detox procedure in a planned Canadian Clinical Trial, with the goal of eventually licensing the protocol around the world.
    8225 views
  • 14 0

  • Comments
  • No comments yet.
06/22/22 - 10:38 AM MatthewDavies created a new post.
  • Account: 1362 SHARES. +60
  • $IBO announced a vital addition of clinical trials director

    Julie Dumouchel has been named Director of Clinical Trials at UI, which is a significant strategic move. Julie Dumouchel has 25 years of experience in the pharmaceutical sector, where she has worked in a variety of clinical research jobs and has a thorough grasp of the drug development process.
    8239 views
  • 10 0

  • Comments
  • No comments yet.
06/22/22 - 08:24 AM MatthewDavies created a new post.
  • Account: 1362 SHARES. +114
  • $IBO to commission ultra- modern addiction treatment center

    At the Kelburn Clinic, UI is developing a cutting-edge holistic addiction treatment protocol that, when combined with the anticipated ibogaine detox programme, will transform the way we treat addiction and dramatically enhance the lives of individuals and families plagued by addiction.
    8303 views
  • 19 0

  • Comments
  • No comments yet.
06/22/22 - 08:22 AM MatthewDavies created a new post.
  • Account: 1362 SHARES. +36
  • Nick Karos excited by listing of UI on Frankfurt stock exchange

    Universal Ibogaine Inc. CEO made a statement "Our capital markets and investor relations strategy includes the FSE listing. We recently began trading on the OTCQB Exchange in the United States, and curiosity in the UI story is growing in Europe, particularly Germany. With a mushrooming market and interest in psychedelic medications, Germany has a reputation for innovation and leadership."
    10647 views
  • 6 0

  • Comments
  • No comments yet.
06/21/22 - 09:53 AM MatthewDavies created a new post.
  • Account: 1362 SHARES. +18
  • $IBO Mr. Shayne Nyquvest, the co-founder of Universal Ibogaine Inc.

    Mr. Shayne Nyquvest co-founded UI in early 2018, after personally seeing the transformational effects and potential of Ibogaine and was involved in UI’s early stage development.
    9419 views
  • 3 0

  • Comments
  • No comments yet.
06/17/22 - 10:20 AM MatthewDavies created a new post.
  • Account: 1362 SHARES. +0
  • Universal Ibogaine market cap assessment

    $IBO has established a remarkable market cap as compared to its fellow penny stocks in the market, currently the market cap is valued at $10.45 Million+
    7217 views
  • 0 0

  • Comments
  • No comments yet.
06/16/22 - 08:50 AM MatthewDavies created a new post.
  • Account: 1362 SHARES. +6
  • Co-Founder of $IBO to present at upcoming research to reality conference.

    Universal Ibogaine Inc.’s Co-Founder Dr. Alberto Sola is going to present at the upcoming research to reality conference: Global Summit on Psychedelic Assisted Therapies and Medicine.
    7657 views
  • 1 0

  • Comments
  • No comments yet.
06/16/22 - 04:46 AM MatthewDavies created a new post.
06/09/22 - 12:09 AM MatthewDavies uploaded a new profile photo.
  • Account: 1362 SHARES. +0

  • 0 0

  • Comments
  • No comments yet.
07:46 PM Ticker  
7:46 PM Ticker